Information  X 
Enter a valid email address

Naspers Limited (NPSN)

  Print      Mail a friend

Tuesday 18 December, 2018

Naspers Limited

SECONDARY LISTING ON A2X

RNS Number : 5373K
Naspers Limited
18 December 2018
 

                                               

NASPERS LIMITED

(Incorporated in the Republic of South Africa)

(Registration number 1925/001431/06)

Share code:  NPN     ISIN: ZAE000015889

LSE ADS code: NPSN  ISIN: US 6315121003

('Naspers' or 'the company')

 

SECONDARY LISTING ON A2X

 

Naspers is pleased to announce that its N ordinary shares have been approved for inclusion in the list of qualifying equity securities to be traded on A2X with effect from 27 December 2018 (the 'A2X listing date').

 

Naspers will retain its primary listing on the Johannesburg Stock Exchange (JSE) and its issued share capital will be unaffected by the secondary listing on A2X. Naspers N ordinary shares will be available to be traded on both the JSE and A2X from the A2X listing date.

 

A2X is a licensed stock exchange authorised to provide a secondary listing venue for companies and is regulated by the Financial Sector Conduct Authority in South Africa in terms of the Financial Markets Act 19 of 2012.

 

Cape Town

18 December 2018

Sponsor: Investec Bank Limited

 

For more information contact:

Shamiela Letsoalo, Media Relations Director South Africa

Tel:          +27 11 289 3750

Mobile:   +27 78 802 6310

Email:      [email protected]

Eoin Ryan, Head of Investor Relations

Tel:          +1 347-210-4305

Email:      [email protected]

 

Meloy Horn, Chief Business Officer

Tel:          +27 11 289 3320 / +27 11 289 4446

Mobile:  +27 82 772 7123

Email:     [email protected]

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCEAEALFDAPFFF

a d v e r t i s e m e n t